Chen Y - Search Results

1

Daratumumab and its potential in the treatment of multiple myeloma: overview of the preclinical and clinical development.

Phipps C, Chen Y, Gopalakrishnan S, Tan D. Phipps C, et al. Among authors: chen y. Ther Adv Hematol. 2015 Jun;6(3):120-7. doi: 10.1177/2040620715572295. Ther Adv Hematol. 2015. PMID: 26137203 Free PMC article. Review.

2

Subcutaneous bortezomib combined with weekly cyclophosphamide and dexamethasone is an efficient and well tolerated regime in newly diagnosed multiple myeloma.

Ong SY, Ng HY, Surendran S, Linn YC, Chen Y, Goh YT, Diong C, Gopalakrishnan SK. Ong SY, et al. Among authors: chen y. Br J Haematol. 2015 Jun;169(5):754-6. doi: 10.1111/bjh.13238. Epub 2014 Nov 21. Br J Haematol. 2015. PMID: 25413901 Free article. No abstract available.

3

Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy.

Phipps C, Chen Y, Tan D. Phipps C, et al. Among authors: chen y. Clin Lymphoma Myeloma Leuk. 2016 Jan;16(1):5-11. doi: 10.1016/j.clml.2015.11.009. Epub 2015 Nov 22. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26705677 Review.

4

Occult recurrence of monomorphic epitheliotropic intestinal T-cell lymphoma and the role of MATK gene expression in diagnosis.

Chen Y, Tan SY, Petersson BF, Khor YM, Gopalakrishnan SK, Tan D. Chen Y, et al. Hematol Oncol. 2017 Dec;35(4):852-855. doi: 10.1002/hon.2288. Epub 2016 Mar 7. Hematol Oncol. 2017. PMID: 26948059

5

Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.

Ong SY, de Mel S, Chen YX, Ooi MG, Surendran S, Lin A, Koh LP, Linn YC, Ho AY, Hwang WY, Phipps C, Loh SM, Goh YT, Tan D, Chng WJ, Gopalakrishnan SK. Ong SY, et al. Among authors: chen yx. Bone Marrow Transplant. 2016 Jul;51(7):933-7. doi: 10.1038/bmt.2016.43. Epub 2016 Mar 14. Bone Marrow Transplant. 2016. PMID: 26974274

6

The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma.

de Mel S, Chen Y, Gopalakrishnan SK, Ooi M, Teo C, Tan D, Teo ML, Tso AC, Lee LK, Nagarajan C, Goh YT, Chng WJ. de Mel S, et al. Among authors: chen y. Singapore Med J. 2017 Feb;58(2):55-71. doi: 10.11622/smedj.2016150. Epub 2016 Sep 9. Singapore Med J. 2017. PMID: 27609508 Free PMC article.

7

The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma.

Phipps C, Lee YS, Ying H, Nagarajan C, Grigoropoulos N, Chen Y, Tang T, Goh AZ, Ghosh A, Ng HJ, Gopalakrishnan S, Loh Y, Lim ST, Hwang W, Tan D, Goh YT. Phipps C, et al. Among authors: chen y. Leuk Lymphoma. 2018 Oct;59(10):2336-2341. doi: 10.1080/10428194.2017.1422863. Epub 2018 Jan 18. Leuk Lymphoma. 2018. PMID: 29345210

8

Pegylated Filgrastim Versus Filgrastim for Stem Cell Mobilization in Multiple Myeloma After Novel Agent Induction.

Abid MB, De Mel S, Abid MA, Yap ES, Gopalakrishnan SK, Chen Y, Yuen YC, Wong HC, Lin A, Poon LM, Koh LP, Chng WJ, Tan LK. Abid MB, et al. Among authors: chen y. Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):174-179. doi: 10.1016/j.clml.2017.12.010. Epub 2018 Jan 5. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29398647

9

Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.

Soekojo CY, Wang GM, Chen Y, Casan J, Wolyncewicz G, Lin A, Poon LM, de Mel S, Koh LP, Tan LK, Ooi MG, Nagarajan C, Liu Y, Lai YY, Huang XJ, Spencer A, Gopalakrishnan SK, Lu J, Chng WJ. Soekojo CY, et al. Among authors: chen y. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e470-e477. doi: 10.1016/j.clml.2019.04.011. Epub 2019 Apr 28. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31171473

10

High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma.

Ong SY, de Mel S, Grigoropoulos NF, Chen Y, Tan YC, Tan MSY, Ng LCK, Lee YS, Phipps C, Goh YT, Yong KY, Liu X, Chng WJ, Lim ST, Nagarajan C. Ong SY, et al. Among authors: chen y. Blood Cancer J. 2021 Aug 12;11(8):143. doi: 10.1038/s41408-021-00535-y. Blood Cancer J. 2021. PMID: 34385415 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165,164 results

Search Page